Antidote
Vendor:
First CVE: Mar 4, 2019 · Active for 7 years
1
Total CVEs
Bottom 1%
1.0
Avg CVEs / Year
Bottom 1%
9.1
Avg CVSS
Higher Avg CVSS than 84% of tracked products
0.0%
KEV Rate
Bottom 1%
Trends Over Time
The number and severity of CVEs published that impact Antidote over time
Volume of CVEsAvg CVSS Base Score
First CVE
Mar 4, 2019
7 years ago
Most Recent CVE
Mar 4, 2019
2,703 days ago
CVE Severity & Scoring
Antidote1 CVEs
100%
All CVEs353,173 CVEs
45%
40%
11%
Critical
Attack Vector
Local0 (0.0%)
Network1 (100.0%)
Unknown0 (0.0%)
Physical0 (0.0%)
Adjacent Network0 (0.0%)
Attack Complexity
Low1 (100.0%)
High0 (0.0%)
Unknown0 (0.0%)
User Interaction
None1 (100.0%)
Unknown0 (0.0%)
Required0 (0.0%)
Privileges Required
Low0 (0.0%)
High0 (0.0%)
None1 (100.0%)
Unknown0 (0.0%)
Top CVEs
Signals from CVEs in this product scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2019-9565CRITICAL Druide Antidote RX, HD, 8 before 8.05.2287, 9 before 9.5.3937 and 10 before 10.1.2147 allows remote attackers to steal NTLM hashes or perform SMB relay attacks upon a direct launch | Mar 4, 2019 | 9.1 | 23 | NO | NO |
Exploit Exposure
Signals from CVEs in this product scope (1 CVEs).
CISA KEV
0 CVEs
0.0% of CVEs· Bottom 1%
Metasploit
0 CVEs
0.0% of CVEs· Bottom 1%
Nuclei
0 CVEs
0.0% of CVEs· Bottom 1%
ExploitDB
0 CVEs
0.0% of CVEs· Bottom 1%
Social Chatter
Signals from CVEs in this product scope (1 CVEs).
Media Mentions
Signals from CVEs in this product scope (1 CVEs).
Top CNAs Publishing CVEs For Antidote
Versions
No cataloged versions.